What is Athlete's Foot Drugs Market?
Athlete’s foot, also known as tinea pedi or ringworm, of the foot is a fungal infection that affects the upper layer of the skin of the foot, especially when it is warm, moist, and irritated. This infection commonly occurs in people whose feet have become very sweaty while confined within tight-fitting shoes. The symptoms of an Athlete’s foot involve itching, stinging and burning. It is treated with over the counter drugs and prescription medications
The market study is being classified by Type (OTC Medications (miconazole, terbinafine, clotrimazole, butenafine and tolnaftate) and Prescription Medications (itraconazole, fluconazole, prescription-strength terbinafine, topical steroid medications, oral antibiotics)) and major geographies with country level break-up.
Mylan N.V. (United States), Novartis International AG (Switzerland), Pfizer Inc. (United States), Merck & Co., Inc. (United States), Sanofi S.A. (France), Bayer AG (Germany), Enzon Pharmaceuticals, Inc. (United States), GlaxoSmithKline plc (United Kingdom), Abbott Laboratories (United States) and Teva Pharmaceutical Industries Ltd. (Israel) are some of the key players profiled in the study.
The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Athlete's Foot Drugs market throughout the predicted period.
Analyst at AMA have segmented the market study of Global Athlete's Foot Drugs market by Type, Application and Region.
On the basis of geography, the market of Athlete's Foot Drugs has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Increased Prevalence of Fungal Infections among People
- Rise in the Number of Hospitals and Diagnostic Centres
- Easy Availability of the OTC (over-the-counter) Medications
- Increased Number of Online Pharmacies
- Less Awareness about Athlete's Foot Treatment
- Increased Research and Development Activities
- Growth in the Healthcare Industry Worldwide
- Stringent Government Rules and Regulations
Key Target AudienceAthlete's Foot Drugs Manufacturers, Raw Material Suppliers, Distributors, Emerging Companies, Research Professionals and End-users
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase